Piper Sandler analyst Edward Tenthoff raised the price target on Skye Bioscience (OTC: SKYE) to $20.00 (from $12.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE